Innovation
15 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport, Emerging technologies; filing pace steady. Cited 2,509 times.
| Year | Filings |
|---|---|
| 2015 | 11 |
| 2016 | 10 |
| 2017 | 8 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 3 |
Investor mix
16 investors on record; lead investors include Partisan Management Group, Alta Partners, Devon Park BioVentures, 3x5 Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 44% |
| Private equity | 3 | 19% |
| Bank & private debt | 2 | 13% |
| Other / undisclosed | 4 | 25% |